Language selection

Government of Canada / Gouvernement du Canada

Search

Alignment among public formularies in Canada, part 3 : medicines assessed by the common drug review.: H82-29/3-2022E-PDF

"This is the last report in a three-part PMPRB series that explores current overlaps and gaps in Canadian public drug plan formularies"--Executive summary, page ii.

Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.907333&sl=0

Publication information
Department/Agency
  • Canada. Patented Medicine Prices Review Board, issuing body.
TitleAlignment among public formularies in Canada, part 3 : medicines assessed by the common drug review.
Publication typeMonograph
Language[English]
Other language editions[French]
FormatDigital text
Electronic document
Note(s)
  • Issued also in French under title: Concordance des listes de médicaments des régimes publics au Canada, partie 3 : médicaments évalués par le programme commun d'évaluation des médicaments.
  • Issued also in HTML format.
  • Includes bibliographical references.
Publishing information
  • Ottawa, ON : Patented Medicine Prices Review Board = Conseil d'examen du prix des médicaments brevetés, February 2022.
  • ©2022
Description1 online resource (iii, 21 pages) : colour charts
ISBN9780660417950
Catalogue number
  • H82-29/3-2022E-PDF
Subject terms
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.

Page details

Report a problem or mistake on this page
Date modified: